Martin F - Search Results

1

Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer.

Ladoire S, Martin F, Ghiringhelli F. Ladoire S, et al. Among authors: martin f. Cancer Immunol Immunother. 2011 Jul;60(7):909-18. doi: 10.1007/s00262-011-1046-y. Epub 2011 Jun 5. Cancer Immunol Immunother. 2011. PMID: 21644034 Free PMC article. Review.

2

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients.

Ghiringhelli F, Menard C, Puig PE, Ladoire S, Roux S, Martin F, Solary E, Le Cesne A, Zitvogel L, Chauffert B. Ghiringhelli F, et al. Among authors: martin f. Cancer Immunol Immunother. 2007 May;56(5):641-8. doi: 10.1007/s00262-006-0225-8. Epub 2006 Sep 8. Cancer Immunol Immunother. 2007. PMID: 16960692 Free PMC article. Clinical Trial.

3

The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression.

Ghiringhelli F, Ménard C, Martin F, Zitvogel L. Ghiringhelli F, et al. Among authors: martin f. Immunol Rev. 2006 Dec;214:229-38. doi: 10.1111/j.1600-065X.2006.00445.x. Immunol Rev. 2006. PMID: 17100888 Review.

4

Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity.

Ménard C, Martin F, Apetoh L, Bouyer F, Ghiringhelli F. Ménard C, et al. Among authors: martin f. Cancer Immunol Immunother. 2008 Nov;57(11):1579-87. doi: 10.1007/s00262-008-0505-6. Epub 2008 Mar 28. Cancer Immunol Immunother. 2008. PMID: 18369619 Free PMC article. Review.

5

Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells.

Ladoire S, Arnould L, Apetoh L, Coudert B, Martin F, Chauffert B, Fumoleau P, Ghiringhelli F. Ladoire S, et al. Among authors: martin f. Clin Cancer Res. 2008 Apr 15;14(8):2413-20. doi: 10.1158/1078-0432.CCR-07-4491. Clin Cancer Res. 2008. PMID: 18413832

6

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity.

Vincent J, Mignot G, Chalmin F, Ladoire S, Bruchard M, Chevriaux A, Martin F, Apetoh L, Rébé C, Ghiringhelli F. Vincent J, et al. Among authors: martin f. Cancer Res. 2010 Apr 15;70(8):3052-61. doi: 10.1158/0008-5472.CAN-09-3690. Epub 2010 Apr 13. Cancer Res. 2010. PMID: 20388795

7

In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival.

Ladoire S, Mignot G, Dabakuyo S, Arnould L, Apetoh L, Rébé C, Coudert B, Martin F, Bizollon MH, Vanoli A, Coutant C, Fumoleau P, Bonnetain F, Ghiringhelli F. Ladoire S, et al. Among authors: martin f. J Pathol. 2011 Jul;224(3):389-400. doi: 10.1002/path.2866. Epub 2011 Mar 25. J Pathol. 2011. PMID: 21437909

8

Role of myeloid-derived suppressor cells in tumor immunotherapy.

Martin F, Apetoh L, Ghiringhelli F. Martin F, et al. Immunotherapy. 2012 Jan;4(1):43-57. doi: 10.2217/imt.11.154. Immunotherapy. 2012. PMID: 22150000 Review.

9

Human FOXP3 and cancer.

Martin F, Ladoire S, Mignot G, Apetoh L, Ghiringhelli F. Martin F, et al. Oncogene. 2010 Jul 22;29(29):4121-9. doi: 10.1038/onc.2010.174. Epub 2010 May 24. Oncogene. 2010. PMID: 20498631 Review.

10

Freshly isolated bone marrow cells induce death of various carcinoma cell lines.

Larmonier N, Ghiringhelli F, Larmonier CB, Moutet M, Fromentin A, Baulot E, Solary E, Bonnotte B, Martin F. Larmonier N, et al. Among authors: martin f. Int J Cancer. 2003 Dec 10;107(5):747-56. doi: 10.1002/ijc.11463. Int J Cancer. 2003. PMID: 14566824 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,455 results

Search Page